Joint pain is an extremely common cause of pain and disability; in fact one in three UK adults over the age of 45 are seeking treatment for it. As part of this, Osteoarthritis (OA) is the most common cause of mechanical joint pain with over 8.75 million people aged 45 and over having sought treatment for it.
With increasing life expectancy and an ever-growing incidence of obesity in the UK, the role of the pharmacy team in the management of joint pain looks set to continue to rise; how can you help your patients overcome this and give them back the joy of movement?
GSK, the manufacturer of Voltarol, the market leading topical NSAID in pharmacy, has a mission to help people do more, feel better, live longer and has a responsibility to ensure the appropriate use of medicines and care for patients.
Voltarol provides clinically proven relief to patients with joint pain. The Voltarol range, available in different formats such as medicated gel, plaster and non-medicated heat patch, can also provide relief for other types of body pain, including muscle and neck pain.
Dr Soha Dattani, Director Scientific Affairs Consumer Healthcare, comments: “OA is one of the most common forms of arthritis, a growing condition which affects millions of people across the UK, impacting on their everyday lives. Community pharmacists are in a unique and trusted position to play a bigger role in front line management, to support joint pain sufferers and help them live a fuller life.
GSK is helping pharmacy teams fully understand the condition and how they can help their patients treat it. For more information, please visit: www.jointpainpartners.gsk.com.